Our findings, combined with existing data showing the increased power of incorporating ApoE ε4 carrier status in predicting conversion from MCI to AD, underscore the importance of studying the metabolic effects of the ApoE ε4 allele specifically among individuals with MCI. Here, APOE is linked to Alzheimer disease.